|
|||||||
![]() | |||||||
| Price + |
| Intraday Chart |
| Financials |
| News |
| Messages |
| Reports |
| Block Deals |
| Corporate Announcements |
| MF Holdings |
| Compare with Peer |
| ads by google |
By Anichya Shah, CNBC-TV18
Companies with high debt-equity ratio have underperformed the Nifty in the last 30 days.
Very-leveraged companies that have underperformed the Nifty have been bouncing back strongly. Real estate, banking and metals space had been highly oversold for the last 30 days – the market has been in a fair bit of downtrend over the last couple of months or so – so risk aversion has crept into these stocks, which have been highly-leveraged; their debt-equity ratio has been 2:5 and you have seen a fair bit of selling pressure.
If one looks at the universal BSE 500 stocks, one sees a debt-equity ratio of greater than 5, sell-off more than 15% off the Nifty underperformance. Some other examples are:
30 Day Returns Vs Nifty (%)
D/E > 5x -14.7
D/E: 2-5x -13.5
D/E: 1-2x -8.7
D/E: 0.5-1x -8.9
D/E <0.5x -5.0
Some stocks with high leverage that have underperformed the Nifty:
D/E Ratio 30D Returns Vs Nifty
Orchid Chem 3.26 -41.02%
Kotak Mah Bank 3.44 -27.49%
Wire & Wireless 5.43 -24.94%
Ispat Industries 4.89 -23.06%
Mundra Port 2.73 -22.01%
IVR Prime 4.05 -24.86%
In the meantime, we have seen a trend where there is a clear shift to low leverage stocks; to defensive plays like Mahindra and Mahindra, Ambuja Cement, Godrej – lot of the pharma stocks as well. They have significantly low debt-equity ratio and have outperformed the Nifty over the last month.
D/E Ratio 30D Returns Vs Nifty
M&M 0.46 15.66%
Ambuja Cem 0.25 19.23%
Godrej Cons 1.02 26.12%
Sun Pharma 0.44 26.35%
Ranbaxy 1.35 26.91%
|
|
| Related links: | |





Offline
523.55 3.99%